Global CRO Services for BioPharma 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07246228

Publication Date:

July 18, 2024

Pages:

157

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
The global CRO Services for BioPharma market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐RO Services for BioPharma Industry Forecast鈥� looks at past sales and reviews total world CRO Services for BioPharma sales in 2022, providing a comprehensive analysis by region and market sector of projected CRO Services for BioPharma sales for 2023 through 2029. With CRO Services for BioPharma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRO Services for BioPharma industry.
This Insight Report provides a comprehensive analysis of the global CRO Services for BioPharma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRO Services for BioPharma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global CRO Services for BioPharma market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRO Services for BioPharma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRO Services for BioPharma.
United States market for CRO Services for BioPharma is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for CRO Services for BioPharma is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for CRO Services for BioPharma is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key CRO Services for BioPharma players cover PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of CRO Services for BioPharma market by product type, application, key players and key regions and countries.
Segmentation by Type:
Preclinical CRO
Clinical Trial CRO
Segmentation by Application:
Commercial
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Preclinical CRO
Clinical Trial CRO
Segmentation by Application:
Commercial
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PPD (Thermo Fisher)
Space Peptides
Aurigene Pharmaceutical Services
IQVIA
Labcorp Drug Development
Parexel
ICON plc
Syneos Health
Charles River Laboratories
Medpace
SGS SA
KCR CRO
TFS HealthScience
Caidya
Worldwide Clinical Trials
CTI
Advanced Clinical
WuXi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
JOINN Laboratories
MEDICILON

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global CRO Services for BioPharma 麻豆原创 Size 2019-2030
2.1.2 CRO Services for BioPharma 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for CRO Services for BioPharma by Country/Region, 2019, 2023 & 2030
2.2 CRO Services for BioPharma Segment by Type
2.2.1 Preclinical CRO
2.2.2 Clinical Trial CRO
2.3 CRO Services for BioPharma 麻豆原创 Size by Type
2.3.1 CRO Services for BioPharma 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CRO Services for BioPharma 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 CRO Services for BioPharma Segment by Application
2.4.1 Commercial
2.4.2 Scientific Research
2.4.3 Other
2.5 CRO Services for BioPharma 麻豆原创 Size by Application
2.5.1 CRO Services for BioPharma 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CRO Services for BioPharma 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 CRO Services for BioPharma 麻豆原创 Size by Player
3.1 CRO Services for BioPharma 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global CRO Services for BioPharma Revenue by Player (2019-2024)
3.1.2 Global CRO Services for BioPharma Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global CRO Services for BioPharma Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRO Services for BioPharma by Region
4.1 CRO Services for BioPharma 麻豆原创 Size by Region (2019-2024)
4.2 Global CRO Services for BioPharma Annual Revenue by Country/Region (2019-2024)
4.3 Americas CRO Services for BioPharma 麻豆原创 Size Growth (2019-2024)
4.4 APAC CRO Services for BioPharma 麻豆原创 Size Growth (2019-2024)
4.5 Europe CRO Services for BioPharma 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa CRO Services for BioPharma 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas CRO Services for BioPharma 麻豆原创 Size by Country (2019-2024)
5.2 Americas CRO Services for BioPharma 麻豆原创 Size by Type (2019-2024)
5.3 Americas CRO Services for BioPharma 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRO Services for BioPharma 麻豆原创 Size by Region (2019-2024)
6.2 APAC CRO Services for BioPharma 麻豆原创 Size by Type (2019-2024)
6.3 APAC CRO Services for BioPharma 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRO Services for BioPharma 麻豆原创 Size by Country (2019-2024)
7.2 Europe CRO Services for BioPharma 麻豆原创 Size by Type (2019-2024)
7.3 Europe CRO Services for BioPharma 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRO Services for BioPharma by Region (2019-2024)
8.2 Middle East & Africa CRO Services for BioPharma 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa CRO Services for BioPharma 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global CRO Services for BioPharma 麻豆原创 Forecast
10.1 Global CRO Services for BioPharma Forecast by Region (2025-2030)
10.1.1 Global CRO Services for BioPharma Forecast by Region (2025-2030)
10.1.2 Americas CRO Services for BioPharma Forecast
10.1.3 APAC CRO Services for BioPharma Forecast
10.1.4 Europe CRO Services for BioPharma Forecast
10.1.5 Middle East & Africa CRO Services for BioPharma Forecast
10.2 Americas CRO Services for BioPharma Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 CRO Services for BioPharma Forecast
10.2.2 Canada 麻豆原创 CRO Services for BioPharma Forecast
10.2.3 Mexico 麻豆原创 CRO Services for BioPharma Forecast
10.2.4 Brazil 麻豆原创 CRO Services for BioPharma Forecast
10.3 APAC CRO Services for BioPharma Forecast by Region (2025-2030)
10.3.1 China CRO Services for BioPharma 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 CRO Services for BioPharma Forecast
10.3.3 Korea 麻豆原创 CRO Services for BioPharma Forecast
10.3.4 Southeast Asia 麻豆原创 CRO Services for BioPharma Forecast
10.3.5 India 麻豆原创 CRO Services for BioPharma Forecast
10.3.6 Australia 麻豆原创 CRO Services for BioPharma Forecast
10.4 Europe CRO Services for BioPharma Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 CRO Services for BioPharma Forecast
10.4.2 France 麻豆原创 CRO Services for BioPharma Forecast
10.4.3 UK 麻豆原创 CRO Services for BioPharma Forecast
10.4.4 Italy 麻豆原创 CRO Services for BioPharma Forecast
10.4.5 Russia 麻豆原创 CRO Services for BioPharma Forecast
10.5 Middle East & Africa CRO Services for BioPharma Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 CRO Services for BioPharma Forecast
10.5.2 South Africa 麻豆原创 CRO Services for BioPharma Forecast
10.5.3 Israel 麻豆原创 CRO Services for BioPharma Forecast
10.5.4 Turkey 麻豆原创 CRO Services for BioPharma Forecast
10.6 Global CRO Services for BioPharma Forecast by Type (2025-2030)
10.7 Global CRO Services for BioPharma Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 CRO Services for BioPharma Forecast
11 Key Players Analysis
11.1 PPD (Thermo Fisher)
11.1.1 PPD (Thermo Fisher) Company Information
11.1.2 PPD (Thermo Fisher) CRO Services for BioPharma Product Offered
11.1.3 PPD (Thermo Fisher) CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 PPD (Thermo Fisher) Main Business Overview
11.1.5 PPD (Thermo Fisher) Latest Developments
11.2 Space Peptides
11.2.1 Space Peptides Company Information
11.2.2 Space Peptides CRO Services for BioPharma Product Offered
11.2.3 Space Peptides CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Space Peptides Main Business Overview
11.2.5 Space Peptides Latest Developments
11.3 Aurigene Pharmaceutical Services
11.3.1 Aurigene Pharmaceutical Services Company Information
11.3.2 Aurigene Pharmaceutical Services CRO Services for BioPharma Product Offered
11.3.3 Aurigene Pharmaceutical Services CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Aurigene Pharmaceutical Services Main Business Overview
11.3.5 Aurigene Pharmaceutical Services Latest Developments
11.4 IQVIA
11.4.1 IQVIA Company Information
11.4.2 IQVIA CRO Services for BioPharma Product Offered
11.4.3 IQVIA CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 IQVIA Main Business Overview
11.4.5 IQVIA Latest Developments
11.5 Labcorp Drug Development
11.5.1 Labcorp Drug Development Company Information
11.5.2 Labcorp Drug Development CRO Services for BioPharma Product Offered
11.5.3 Labcorp Drug Development CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Labcorp Drug Development Main Business Overview
11.5.5 Labcorp Drug Development Latest Developments
11.6 Parexel
11.6.1 Parexel Company Information
11.6.2 Parexel CRO Services for BioPharma Product Offered
11.6.3 Parexel CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Parexel Main Business Overview
11.6.5 Parexel Latest Developments
11.7 ICON plc
11.7.1 ICON plc Company Information
11.7.2 ICON plc CRO Services for BioPharma Product Offered
11.7.3 ICON plc CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 ICON plc Main Business Overview
11.7.5 ICON plc Latest Developments
11.8 Syneos Health
11.8.1 Syneos Health Company Information
11.8.2 Syneos Health CRO Services for BioPharma Product Offered
11.8.3 Syneos Health CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Syneos Health Main Business Overview
11.8.5 Syneos Health Latest Developments
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Information
11.9.2 Charles River Laboratories CRO Services for BioPharma Product Offered
11.9.3 Charles River Laboratories CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Charles River Laboratories Main Business Overview
11.9.5 Charles River Laboratories Latest Developments
11.10 Medpace
11.10.1 Medpace Company Information
11.10.2 Medpace CRO Services for BioPharma Product Offered
11.10.3 Medpace CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Medpace Main Business Overview
11.10.5 Medpace Latest Developments
11.11 SGS SA
11.11.1 SGS SA Company Information
11.11.2 SGS SA CRO Services for BioPharma Product Offered
11.11.3 SGS SA CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 SGS SA Main Business Overview
11.11.5 SGS SA Latest Developments
11.12 KCR CRO
11.12.1 KCR CRO Company Information
11.12.2 KCR CRO CRO Services for BioPharma Product Offered
11.12.3 KCR CRO CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 KCR CRO Main Business Overview
11.12.5 KCR CRO Latest Developments
11.13 TFS HealthScience
11.13.1 TFS HealthScience Company Information
11.13.2 TFS HealthScience CRO Services for BioPharma Product Offered
11.13.3 TFS HealthScience CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 TFS HealthScience Main Business Overview
11.13.5 TFS HealthScience Latest Developments
11.14 Caidya
11.14.1 Caidya Company Information
11.14.2 Caidya CRO Services for BioPharma Product Offered
11.14.3 Caidya CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Caidya Main Business Overview
11.14.5 Caidya Latest Developments
11.15 Worldwide Clinical Trials
11.15.1 Worldwide Clinical Trials Company Information
11.15.2 Worldwide Clinical Trials CRO Services for BioPharma Product Offered
11.15.3 Worldwide Clinical Trials CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Worldwide Clinical Trials Main Business Overview
11.15.5 Worldwide Clinical Trials Latest Developments
11.16 CTI
11.16.1 CTI Company Information
11.16.2 CTI CRO Services for BioPharma Product Offered
11.16.3 CTI CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 CTI Main Business Overview
11.16.5 CTI Latest Developments
11.17 Advanced Clinical
11.17.1 Advanced Clinical Company Information
11.17.2 Advanced Clinical CRO Services for BioPharma Product Offered
11.17.3 Advanced Clinical CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Advanced Clinical Main Business Overview
11.17.5 Advanced Clinical Latest Developments
11.18 WuXi AppTec
11.18.1 WuXi AppTec Company Information
11.18.2 WuXi AppTec CRO Services for BioPharma Product Offered
11.18.3 WuXi AppTec CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 WuXi AppTec Main Business Overview
11.18.5 WuXi AppTec Latest Developments
11.19 Pharmaron Inc.
11.19.1 Pharmaron Inc. Company Information
11.19.2 Pharmaron Inc. CRO Services for BioPharma Product Offered
11.19.3 Pharmaron Inc. CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Pharmaron Inc. Main Business Overview
11.19.5 Pharmaron Inc. Latest Developments
11.20 Hangzhou Tigermed Consulting
11.20.1 Hangzhou Tigermed Consulting Company Information
11.20.2 Hangzhou Tigermed Consulting CRO Services for BioPharma Product Offered
11.20.3 Hangzhou Tigermed Consulting CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Hangzhou Tigermed Consulting Main Business Overview
11.20.5 Hangzhou Tigermed Consulting Latest Developments
11.21 JOINN Laboratories
11.21.1 JOINN Laboratories Company Information
11.21.2 JOINN Laboratories CRO Services for BioPharma Product Offered
11.21.3 JOINN Laboratories CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 JOINN Laboratories Main Business Overview
11.21.5 JOINN Laboratories Latest Developments
11.22 MEDICILON
11.22.1 MEDICILON Company Information
11.22.2 MEDICILON CRO Services for BioPharma Product Offered
11.22.3 MEDICILON CRO Services for BioPharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 MEDICILON Main Business Overview
11.22.5 MEDICILON Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.